porcin
epidem
diarrhea
viru
pedv
first
describ
europ
recent
sever
outbreak
asia
viru
identifi
unit
state
may
caus
sever
diarrhea
vomit
pig
across
age
group
high
mortal
suckl
pig
pedv
envelop
singl
strand
rna
viru
belong
coronavirida
famili
coronavirus
taxonom
form
subfamili
coronavirina
within
order
nidoviral
recent
intern
committe
taxonomi
virus
ictv
recogn
four
genera
within
coronavirina
subfamili
alphacoronaviru
betacoronaviru
gammacoronaviru
deltacoronaviru
pedv
belong
genu
alphacoronaviru
along
swine
virus
includ
transmiss
gastroenter
viru
tgev
porcin
respiratori
coronaviru
prcv
genom
compos
larg
kb
molecul
consist
untransl
region
utr
utr
least
seven
open
read
frame
orf
encod
three
nonstructur
protein
accessori
protein
four
major
structur
protein
matur
virion
includ
spike
glycoprotein
mr
kda
nucleoprotein
np
mr
kda
associ
posit
strand
rna
provid
integr
support
helic
structur
glycosyl
membran
protein
mr
kda
glycosyl
envelop
protein
e
mr
kda
coronavirus
taxonom
assign
differ
genera
base
root
phylogeni
calcul
evolutionari
distanc
seven
highli
conserv
genom
domain
within
orf
genet
divers
coronavirus
may
due
high
frequenc
recombin
heterogen
among
coronaviru
subfamili
well
document
factor
contribut
pedv
abil
gain
lose
part
transcriptom
believ
contribut
quasispeci
novel
trait
abl
adapt
new
host
ecolog
nich
zoonot
event
exact
origin
pedv
north
america
entir
clear
evid
genet
similar
chines
pedv
strain
recent
novel
na
pedv
recombin
strain
identifi
indel
contain
insert
delet
within
ntermin
domain
orf
gene
specif
sequenc
align
indic
spike
gene
nucleotid
delet
posit
correspond
amino
acid
delet
posit
addit
substitut
posit
h
k
e
compar
related
sever
pedv
strain
circul
china
evalu
li
et
al
use
phylogen
analysi
np
gene
insert
delet
note
sequenc
comparison
european
korean
pedv
strain
obtain
genbank
indic
np
gene
highli
conserv
even
though
strain
origin
differ
geograph
region
addit
highli
conserv
among
pedv
variant
np
abund
viral
protein
express
pedv
infect
cell
contrast
spike
protein
present
viral
surfac
subject
variou
host
immun
pressur
predispos
greater
rang
genet
heterogen
includ
insert
delet
np
protein
highli
abund
viru
infect
cell
provid
attract
target
develop
antigenbas
serolog
assay
taken
togeth
evid
provid
rational
use
antigen
choic
ielisa
belisa
fmia
respons
recent
outbreak
highli
virul
pedv
north
america
na
pcr
assay
quickli
develop
detect
presenc
pedv
rna
intestin
fecal
materi
assay
provid
import
tool
control
viru
howev
wellvalid
highthroughput
assay
detect
antibodi
follow
infect
would
provid
addit
valuabl
diagnost
tool
swine
industri
abil
detect
evalu
antibodi
respons
use
serolog
test
import
effort
answer
basic
product
relat
question
question
may
includ
whether
product
site
histor
experienc
pedv
exposur
even
though
produc
seen
obviou
clinic
sign
level
immun
respons
sow
may
relat
vaccin
initi
wildtyp
viru
infect
intent
feedback
exposur
whether
sow
immun
inadequ
clinic
infect
occur
individu
litter
initi
pedv
exposur
herd
one
press
issu
pedv
diseas
maintain
herd
site
biosecur
exclus
measur
prevent
viral
entranc
swine
unit
howev
pedv
infect
may
alway
obviou
finish
pig
widespread
transport
anim
may
repres
addit
risk
thu
sensit
serolog
test
provid
valuabl
tool
detect
recent
infect
avoid
introduct
anim
herd
sinc
pedv
widespread
europ
recent
asia
variou
serolog
test
develop
subject
vari
degre
valid
howev
assay
develop
use
antigen
associ
contemporari
strain
current
circul
across
na
need
develop
sensit
serolog
assay
becom
paramount
order
address
question
regard
pedv
infect
epidemiolog
transmiss
pattern
well
analyz
diseas
progress
current
serum
viru
neutral
svn
test
wide
employ
serolog
assay
use
detect
pedv
antibodi
test
highli
specif
use
screen
antibodi
titer
post
vaccin
howev
test
expens
labor
intens
requir
manual
read
interpret
viru
induc
cytopath
effect
cpe
endpoint
moreov
serum
cytotox
mistaken
viral
cpe
give
rise
fals
interpret
lower
serum
dilut
sever
laboratori
gener
inhous
indirect
elisa
use
either
viru
deriv
antigen
recombin
structur
protein
earli
indirect
elisa
develop
use
vero
cell
deriv
whole
viru
prepar
vero
cell
express
viral
protein
method
may
problemat
serum
anim
vaccin
cell
cultur
deriv
pedv
may
crossreact
cellular
compon
elisa
antigen
caus
low
specif
high
background
group
use
recombinantli
express
purifi
structur
np
protein
ielisa
serodiagnosi
low
number
experiment
deriv
sampl
use
evalu
perform
assay
full
valid
diagnost
sensit
specif
could
assess
ielisa
belisa
format
proven
use
serodiagnosi
experiment
natur
infect
block
competit
elisa
shown
especi
use
higher
level
specif
requir
increas
specif
shown
depend
isotyp
target
specif
monoclon
polyclon
antibodi
variou
laboratori
develop
sensit
block
elisa
carvaj
et
al
demonstr
belisa
abl
detect
antibodi
respons
day
earlier
ifa
suggest
higher
sensit
belisa
addit
belisa
valuabl
confirmatori
test
unexpect
posit
result
appear
presum
neg
herd
fluoresc
microspher
immunoassay
base
fluidic
particl
array
technolog
luminex
corp
austin
tx
becom
increasingli
standard
accept
applic
involv
serolog
diagnosi
autoimmun
anim
infecti
diseas
distinct
advantag
fmia
elisa
includ
higher
sensit
higher
sampl
throughput
analysi
abil
multiplex
monitor
exposur
multipl
pathogen
simultan
singl
sampl
addit
multipl
bead
set
fmia
could
ad
standard
assay
newer
viru
subtyp
continu
emerg
field
assess
antigenicphylogenet
differ
genera
coronavirus
studi
report
adapt
recombin
highli
purifi
na
pedvnp
antigen
develop
ielisa
belisa
fmia
platform
detect
pedv
antibodi
serum
assay
provid
high
throughput
serolog
test
design
address
pedv
diseas
diagnost
fulli
valid
use
larg
number
serum
sampl
known
statu
valid
test
detail
use
method
valid
serolog
assay
diagnosi
infecti
diseas
previous
describ
jacobson
offic
intern
de
epizooti
addit
fluoresc
focu
neutral
ffn
assay
develop
rapid
evalu
neutral
antibodi
respons
time
cours
studi
serum
sampl
experiment
infect
anim
obtain
courtesi
dr
richard
hess
kansa
state
univers
veterinari
diagnost
laboratori
nation
pork
board
grant
thirtythre
pedv
feeder
pig
obtain
privat
highhealth
statu
swine
product
farm
pig
inocul
pedv
week
age
via
intranas
oral
rout
pool
gut
deriv
intestin
content
use
feedback
inocula
control
exposur
sow
herd
serum
collect
prior
challeng
day
day
postinfect
dpi
multipl
aliquot
sampl
collect
share
request
laboratori
expand
diagnost
test
vaccin
develop
capabl
accur
assess
diagnost
sensit
specif
assay
sampl
known
serostatu
pedv
use
includ
sera
multipl
anim
popul
includ
experiment
infect
anim
serum
sampl
anim
known
histor
exposur
pedv
submit
south
dakota
anim
diseas
research
diagnost
laboratori
adrdl
pedv
neg
sampl
set
includ
sampl
pedv
neg
control
pig
use
experiment
studi
select
high
biosecur
herd
histori
pedv
addit
archiv
serum
sampl
collect
prior
emerg
pedv
us
includ
sampl
test
posit
relat
swine
coronavirus
tgev
prcv
n
use
exact
number
posit
neg
sera
use
sensit
specif
calcul
per
assay
statist
test
agreement
calcul
base
serum
number
list
tabl
major
sera
ident
among
assay
limit
serum
volum
allow
use
sera
sampl
among
assay
develop
valid
ielisa
belisa
made
use
recombinantli
express
full
length
na
pedvnp
np
open
read
frame
orf
pedv
amplifi
rna
extract
directli
intestin
content
rtpcr
case
submit
south
dakota
adrdl
subsequ
direct
clone
e
coli
pet
plasmid
express
vector
novagen
madison
wi
transform
plu
rp
compet
cell
stratagen
la
jolla
ca
protein
express
primer
use
amplif
full
length
bp
nucleoprotein
pedvnpfwd
pedvnprev
next
transform
cell
plate
onto
luriabertani
agar
plate
contain
kanamycinml
incub
overnight
follow
morn
coloni
agar
plate
ad
l
prewarm
yeast
extract
trypton
yt
cultur
medium
contain
kanamycinml
allow
grow
pedvnp
express
induc
use
isopropyl
iptg
final
concentr
mm
induc
transcript
lac
operon
e
coli
allow
incub
addit
h
shake
rpm
agar
strain
bacteria
pellet
centrifug
g
min
pellet
resuspend
ml
lysi
buffer
solut
bper
pierc
rockford
il
incub
min
centrifug
g
separ
solubl
insolubl
protein
pedvnp
recombin
protein
express
insolubl
periplasm
inclus
bodi
result
amino
acid
recombin
protein
denatur
use
urea
subsequ
purifi
three
time
use
nickelnta
affin
column
chromatographi
refold
back
nativ
conform
state
individu
affin
column
elut
collect
pool
confirm
sdspage
aliquotedfrozen
correct
nucleotid
sequenc
confirm
sequenc
restrict
endonucleas
analysi
averag
protein
yield
produc
plasmid
construct
calcul
mg
pedvnp
per
liter
aforement
condit
recombin
protein
detect
predict
molecular
weight
kda
confirm
via
western
blot
use
convalesc
sera
histidinespecif
mab
novagen
madison
wi
pedvnp
specif
mab
fig
two
separ
mab
develop
laboratori
recogn
nativ
conform
pedvnp
full
length
linear
recombin
protein
use
antibodi
captur
assay
hybridoma
produc
previous
describ
immunoglobulin
isotyp
result
mab
perform
use
commerci
later
flow
assay
serotec
raleigh
nc
subsequ
mous
ascit
fluid
produc
pristaneprim
mice
antibodi
purifi
biotinyl
use
detect
moieti
belisa
conjug
antibodi
solut
quantifi
via
lowri
protein
method
carrier
bsa
ad
final
concentr
mgml
aliquot
store
cell
atcc
cultur
mem
fb
h
fulli
confluent
plate
wash
twice
mem
subsequ
altern
row
plate
inocul
cell
cultur
adapt
pedv
nvslco
strain
pedv
pedv
genbank
access
number
multipl
infect
moi
mem
supplement
trypsin
tpck
treat
bovin
deriv
sigma
st
loui
mo
incub
h
monolay
fix
aceton
min
serum
sampl
initi
serial
dilut
pb
duplic
well
dilut
serum
ad
well
plate
incub
h
rins
pb
next
fluorescein
isothiocyan
fitc
conjug
goat
antiswin
igg
kpl
west
chester
pa
prepar
dilut
pb
ad
well
h
incub
plate
rins
pb
examin
use
fluoresc
microscopi
individu
test
pedv
infect
well
compar
respect
uninfect
partner
well
posit
sampl
indic
pedv
specif
fluoresc
signal
observ
serum
dilut
greater
sampl
test
duplic
antibodi
titer
express
mean
replic
serolog
pedvnp
indirect
elisa
perform
coat
altern
well
immulon
microtit
plate
thermo
labsystem
franklin
ngwell
purifi
recombinantli
express
pedvnp
antigen
optim
dilut
recombin
protein
secondari
detect
antibodi
determin
checkerboard
titrat
gave
highest
signal
nois
ratio
addit
singl
lot
pool
convalesc
serum
pedv
infect
pig
use
gener
qualiti
control
standard
gave
high
low
optic
densiti
high
od
low
od
neg
od
pedvnp
recombin
protein
dilut
mm
sodium
mm
sodium
bicarbon
antigen
coat
buffer
acb
ph
oddnumb
column
coat
acb
plu
antigen
evennumb
column
coat
acb
without
antigen
serv
background
control
plate
incub
one
hour
wash
pb
plu
pbst
well
block
sampl
milk
diluent
pbst
plu
nonfat
dri
milk
smd
allow
incub
overnight
follow
day
plate
wash
pbst
test
control
sera
dilut
smd
mix
solut
ad
well
plate
incub
h
next
biotinyl
goat
antiswin
detect
antibodi
bethyl
laboratori
tx
ad
concentr
ngml
pbst
allow
incub
h
plate
wash
pbst
streptavidinhrp
conjug
pierc
rockford
il
ad
incub
anoth
hour
wash
develop
tetramethylbenzidin
peroxidas
substrat
tmb
surmod
eden
prairi
mn
color
develop
progress
posit
control
attain
standard
od
stop
use
n
colorimetr
develop
quantifi
spectrophotometr
nm
micropl
reader
biotek
instrument
inc
winooski
vt
control
xcheck
softwar
idexx
laboratori
westbrook
raw
data
normal
transform
excel
spreadsheet
sampl
posit
sp
ratio
calcul
use
follow
formula
sp
optic
densiti
od
sampl
od
bufferod
posit
control
od
buffer
serolog
belisa
perform
use
immulon
microtit
plate
thermo
labsystem
franklin
altern
well
plate
coat
ng
per
well
express
pedvnp
antigen
optim
dilut
recombin
protein
mab
antibodi
determin
checkerboard
titrat
gave
highest
signal
nois
ratio
od
read
approxim
absenc
swine
serumcompetitor
antibodi
first
pedvnp
recombin
protein
dilut
acb
oddnumb
column
coat
acb
plu
antigen
evennumb
column
coat
acb
without
antigen
serv
background
control
plate
incub
h
wash
time
pbst
place
overnight
follow
day
well
block
smd
incub
one
hour
plate
wash
time
pbst
test
control
sera
dilut
pbst
nonfat
dri
milk
ad
duplic
well
plate
incub
h
sampl
incub
pedvnp
specif
biotinyl
mab
adjust
equal
titer
mix
togeth
ratio
next
dilut
antibodi
detect
mixtur
ad
microtit
plate
contain
competit
swine
antibodi
swirl
incub
addit
min
plate
wash
time
high
sensit
streptavidinhorseradish
peroxidas
conjug
pierc
rockford
il
ad
well
microtit
plate
h
plate
wash
time
pbst
tmb
ad
well
gentli
swirl
min
color
develop
progress
neg
control
attain
standard
od
approxim
subsequ
stop
use
n
colorimetr
develop
quantifi
spectrophotometr
nm
micropl
reader
biotek
instrument
inc
winooski
vt
control
xcheck
softwar
idexx
laboratori
westbrook
raw
data
normal
transform
excel
spreadsheet
percent
inhibit
pi
ratio
calcul
use
follow
formula
pi
od
sampl
od
buffer
od
neg
control
od
buffer
x
twostep
carbodiimid
coupl
procedur
use
coupl
na
pedvnp
protein
microspher
briefli
coupl
fluoresc
microspher
perform
wash
microspher
twice
activ
buffer
sonic
wash
microspher
activ
min
activ
buffer
contain
mg
nhydroxysulfosuccinimid
sulfonh
mg
n
dimethylaminopropyl
nethylcarbodiimid
edc
pierc
chemic
rockford
il
activ
microspher
wash
twice
pb
sonic
coupl
initi
addit
recombin
na
pedvnp
protein
brought
final
volum
pb
incub
dark
h
rotat
coupl
microspher
wash
ml
pb
plu
bovin
serum
albumin
pbsnb
next
microspher
block
ml
pbsnb
min
reduc
nonspecif
bind
microspher
wash
twice
pbsnb
resuspend
pbsnb
final
concentr
antigencoupl
microspheresml
hydrophil
membran
filter
plate
block
min
pbsnb
liquid
aspir
via
vacuum
manifold
plate
wet
pbsnb
buffer
prevent
dri
next
serum
dilut
pbsnb
ad
duplic
well
filter
plate
along
pbsnb
contain
antigencoupl
microspher
sinc
microspher
report
moieti
light
sensit
incub
perform
dark
seal
plate
foil
subsequ
fmia
plate
incub
h
plate
shaker
rotat
rpm
plate
wash
time
pbst
next
antiswin
biotinyl
iga
heavi
light
chain
dilut
pbsnb
bethyl
laboratori
iggfc
specif
polyclon
antibodi
dilut
dilut
pbsnb
bethyl
laboratori
ad
filter
plate
incub
h
np
igm
igg
isotypespecif
antibodi
level
detect
use
pedvnp
coat
microspher
speciat
mean
individu
separ
igm
iggspecif
secondari
antibodi
sinc
valid
perform
use
serum
iga
present
low
amount
iga
specif
secondari
antibodi
use
step
incub
secondari
antibodi
streptavidin
phycoerythrin
pbsnb
molecular
probe
ad
well
incub
min
shake
supernat
aspir
plate
wash
time
pbst
final
microspher
resuspend
pbst
per
well
transfer
clear
polystyren
optic
plate
coupl
microspher
analyz
duallas
biorad
bioplex
instrument
median
fluoresc
intens
mfi
microspher
correspond
individu
bead
analyt
record
well
report
mfi
measur
normal
via
f
background
signal
determin
fluoresc
measur
test
sampl
uncoat
bead
f
mfi
serolog
test
sampl
use
antigenco
bead
four
serolog
refer
serum
set
construct
standard
term
high
medium
low
neg
serv
intern
qualiti
control
standard
mathemat
normal
individu
sampl
object
comparison
test
platform
highlabel
standard
design
gener
od
ielisa
belisa
mfi
approxim
fmia
high
standard
use
exclus
mathemat
determin
serolog
respons
sp
ratio
sampl
use
test
valid
medium
standard
gener
respons
od
two
elisa
approxim
mfi
fmia
low
standard
design
deliv
signal
slightli
threshold
level
test
neg
serum
gener
od
mfi
background
level
less
od
elisa
mfi
fmia
accur
assess
diagnost
sensit
specif
assay
sampl
known
serostatu
pedv
use
includ
sera
multipl
anim
popul
includ
experiment
infect
anim
serum
sampl
submit
south
dakota
adrdl
pedv
neg
sampl
set
includ
sampl
select
high
biosecur
herd
histori
pedv
archiv
serum
sampl
collect
prior
emerg
pedv
us
includ
sampl
test
posit
relat
swine
coronavirus
tgev
prcv
known
posit
sampl
collect
pig
natur
infect
least
week
prior
collect
previous
posit
pcr
negativetest
sampl
popul
uninfect
anim
consist
maxim
pedv
neg
serum
sampl
positivetest
infect
popul
compos
serum
sampl
receiv
oper
characterist
roc
analysi
calcul
assay
assess
diagnost
perform
includ
determin
sensit
specif
threshold
cutoff
use
medcalc
version
medcalc
softwar
mariakerk
belgium
repeat
assay
assess
run
intern
qualiti
control
serum
standard
multipl
replic
within
run
run
ielisa
belisa
intraassay
repeat
calcul
replic
separ
plate
repeat
period
interassay
repeat
assess
valu
assay
express
mean
standard
deviat
percent
coeffici
variat
cv
repeat
measur
multipl
comparison
interrat
agreement
kappa
measur
associ
calcul
among
four
test
belisa
ielisa
fmia
ifa
use
ibm
spss
version
softwar
spss
inc
chicago
il
sampl
cohort
use
wellcharacter
set
serum
sampl
collect
posit
test
experiment
infect
pig
time
courtesi
dr
richard
hess
n
archiv
experiment
control
uninfect
pedv
neg
test
anim
interpret
kappa
rate
follow
kappa
less
poor
agreement
slight
agreement
fair
agreement
moder
agreement
substanti
agreement
almost
perfect
agreement
pedv
viru
neutral
assay
use
ffn
format
develop
rapid
detect
neutral
antibodi
produc
respons
pedv
infect
ffn
evalu
use
serum
sampl
rennet
treat
milk
colostrum
sampl
heatinactiv
sampl
dilut
dilut
seri
start
mem
plu
tpcktreat
trypsin
plate
equal
amount
cell
cultur
adapt
pedv
stock
concentr
foci
form
ad
well
plate
incub
h
virussampl
mixtur
ad
wash
confluent
monolay
cell
incub
h
plate
wash
memtpcktrypsin
medium
incub
h
allow
replic
nonneutr
viru
plate
fix
aceton
stain
fitc
conjug
mab
allow
visual
infect
cell
endpoint
neutral
titer
determin
highest
serum
milk
colostrum
dilut
result
greater
reduct
fluoresc
foci
rel
control
shown
fig
puriti
recombin
protein
assess
via
sdspage
gave
band
migrat
correspond
expect
molecular
mass
kda
upon
stain
coomassi
brilliant
blue
protein
yield
iptg
induc
e
coli
cultur
calcul
approxim
mg
pedvnplit
medium
puriti
greater
ident
protein
character
western
blot
use
convalesc
swine
serum
antihi
mab
antipedvnp
mab
fig
optim
serolog
assay
variou
antigen
serum
dilut
use
determin
optimum
concentr
test
optim
checkerboard
fashion
maxim
signaltonois
ratio
determin
antigen
titrat
optim
coat
microspher
achiev
concentr
protein
per
microspher
similarli
optimum
coat
ielisa
belisa
plate
achiev
concentr
ngwell
addit
determin
optimum
serum
dilut
test
platform
wellcharacter
pedv
high
posit
serum
standard
serial
dilut
titrat
antigen
coat
microspher
fmia
antigen
coat
elisa
well
fix
concentr
figur
show
concentrationdepend
od
mfi
signal
variou
serum
standard
overal
sampl
absorb
increas
invers
proport
serum
dilut
howev
base
upon
highest
signaltonois
ratio
determin
optim
serum
dilut
belisa
ielisa
fmia
demonstr
optimum
dilut
indic
arrow
fig
roc
analysi
determin
sensit
specif
threshold
cutoff
level
perform
use
larg
number
swine
serum
sampl
demonstr
excel
agreement
kappa
score
assay
good
intra
inter
assay
repeat
tabl
none
known
posit
tgev
prcv
sampl
test
shown
crossreact
optim
cutoff
valu
correspond
sensit
specif
individu
test
present
fig
specif
roc
analysi
ielisa
belisa
show
similar
sensit
specif
respect
roc
analysi
fmia
show
estim
sensit
specif
respect
although
fmia
show
ident
sensit
belisa
demonstr
highest
degre
specif
three
assay
observ
surpris
given
fmia
technolog
inher
impart
greater
sensit
larger
dynam
rang
elisa
platform
addit
determin
cutoff
valu
sensit
specif
multipl
comparison
test
perform
calcul
degre
agreement
among
elisa
fmia
ifa
test
specif
kappa
test
demonstr
diagnost
platform
kappa
valu
greater
demonstr
test
almost
perfect
agreement
ielisa
belisa
demonstr
slightli
lower
cv
fmia
intraassay
variabl
belisa
ielisa
fmia
respect
interassay
cv
belisa
ielisa
fmia
respect
nonetheless
cv
less
demonstr
test
highli
repeat
diagnost
applic
shown
fig
mean
antibodi
respons
pedvnp
could
detect
earli
dpi
ielisa
belisa
fmia
detect
pedvnp
antibodi
slightli
earlier
dpi
test
detect
durat
antibodi
dpi
timepoint
studi
demonstr
declin
detect
antibodi
dpi
high
level
pedvnp
specif
igm
antibodi
observ
dpi
compar
igg
fig
howev
igm
antibodi
decreas
bare
detect
level
dpi
igg
continu
increas
linearli
dpi
concomit
appear
neutral
antibodi
dpi
ffn
assay
initi
evalu
use
sequenti
serum
sampl
experiment
inocul
piglet
addit
evalu
conduct
use
serum
sampl
known
pedv
herd
sampl
herd
document
pedv
exposur
collect
least
week
initi
pcr
diagnosi
whole
herd
feedback
experiment
inocul
piglet
demonstr
detect
seroconvers
dpi
fig
essenti
sampl
pedv
anim
serum
ffn
endpoint
titer
sampl
pedv
posit
set
endpoint
titer
rang
data
shown
evalu
ffn
includ
serum
milk
colostrum
sampl
sow
herd
experienc
acut
pedv
outbreak
week
prior
farrow
anim
expos
live
viru
twice
within
first
week
outbreak
follow
one
dose
harrisvaccin
porcin
epidem
diarrhea
vaccin
rna
harrisvaccin
inc
ame
ia
week
prefarrow
serum
colostrum
sampl
test
time
farrow
follow
serum
milk
sampl
week
week
later
shown
fig
mean
colostrum
titer
approxim
higher
serum
titer
time
farrow
later
timepoint
serum
milk
titer
similar
magnitud
although
substanti
anim
anim
variat
appar
overal
repertoir
assay
use
initi
identif
effici
high
throughput
quantit
pedv
antibodi
evalu
three
diagnost
platform
well
character
ifa
compar
individu
serum
igm
igg
kinet
antibodi
respons
fmia
appear
neutral
antibodi
detect
ffn
assay
antibodycaptur
assay
valid
use
larg
number
serum
sampl
n
base
upon
assay
valid
method
jacobson
support
offic
intern
de
epizooti
sinc
pedv
first
identifi
us
may
spread
rapidli
least
state
wwwaasvorg
report
mexico
canada
viru
caus
sever
gastroenter
destroy
villu
enterocyt
pig
age
character
vomit
diarrhea
lead
subsequ
dehydr
high
mortal
rate
econom
loss
particularli
nurseri
piglet
varieti
serolog
test
develop
pedv
vari
antigen
use
degre
valid
addit
use
north
american
np
base
antigen
compar
array
serolog
assay
describ
current
studi
four
test
ifa
belisa
ielisa
fmia
show
strong
correl
advantag
dictat
use
field
addit
newli
develop
np
mab
use
belisa
expedit
ffn
test
detect
neutral
antibodi
develop
elisa
fmia
full
length
na
pedvnp
gene
amplifi
directli
rna
extract
pedvinfect
ileal
tissu
multipl
sequenc
align
analysi
show
amplifi
np
gene
share
nucleotid
homolog
us
colorado
strain
isol
genbank
access
sever
author
confirm
np
carri
multipl
antigen
determin
conserv
among
coronavirida
howev
perform
oneway
crossreact
test
use
serum
tgev
prcv
antibodi
crossreact
detect
within
assay
addit
highli
conserv
among
variou
pedv
variant
np
abund
viral
protein
express
pedv
infect
cell
make
attract
target
antigen
use
western
blot
experi
confirm
find
hou
et
al
observ
level
express
np
protein
significantli
higher
level
spike
protein
studi
demonstr
possibl
achiev
protein
yield
mg
per
liter
cultur
puriti
greater
recombin
np
previous
identifi
use
antigen
elisa
develop
detect
antibodi
pig
locat
china
korea
studi
hou
et
al
author
show
similar
sensit
specif
ielisa
compar
ielisa
describ
studi
howev
smaller
number
known
posit
neg
sampl
evalu
current
studi
sinc
test
specif
belisa
develop
use
confirmatori
test
due
higher
inher
specif
ielisa
block
competit
elisa
construct
use
monoclon
antibodi
pedv
serodiagnosi
specif
methodolog
affect
overal
specif
perform
assay
method
base
upon
coat
plate
highli
purifi
na
pedvnp
use
combin
two
separ
na
anti
pedvnp
specif
biotinyl
monoclon
antibodi
blockingcompetit
detect
step
allow
captur
antinp
antibodi
higher
quantiti
greater
rang
antigen
specif
analyt
specif
npbase
belisa
also
depend
affin
mab
use
antibodi
use
studi
direct
conserv
epitop
nucleocapsid
protein
without
evid
crossreact
genera
alphacoronaviru
test
previou
assess
antigen
crossreact
perform
use
mab
differ
strain
pedv
tgev
studi
author
report
mab
use
belisa
react
pedv
strain
test
name
homolog
us
isol
heterolog
strain
indel
iowa
similar
titer
neither
pedvnp
mab
crossreact
either
tgev
miller
purdu
strain
belisa
mab
test
heterolog
crossreact
three
diagnost
platform
evalu
abil
captur
antibodi
tgev
prcv
crossreact
either
heterolog
viru
serolog
test
ifa
ielisa
belisa
fmia
use
determin
whether
pig
previous
infect
pedv
piglet
acquir
antibodi
colostrum
eg
passiv
antibodi
transfer
howev
test
evalu
function
antibodi
ffn
need
determin
detect
immun
respons
could
help
provid
protect
nurs
piglet
neutral
antibodi
may
protect
action
includ
block
uptak
viru
cell
prevent
viru
bind
receptor
cell
prevent
uncoat
viru
genom
endosom
andor
caus
aggreg
viru
particl
envelop
virus
pedv
lysi
viru
may
also
occur
antivir
antibodi
serum
complement
disrupt
viral
membran
reason
ffnbase
viru
neutral
assay
develop
assess
level
pedv
neutral
antibodi
serum
milk
colostrum
sampl
ffn
provid
rapid
determin
neutral
antibodi
level
possibl
tradit
viru
neutral
assay
reli
visual
virusinduc
cpe
three
day
incub
allow
full
develop
pedv
cpe
direct
observ
fluoresc
stain
infect
cell
lack
stain
infect
cell
case
viru
neutral
allow
simpl
endpoint
determin
featur
particularli
valuabl
deal
fastidi
trypsindepend
viru
pedv
cpebas
endpoint
may
obviou
may
confus
trypsininduc
cpe
cell
monolay
although
neutral
antibodi
present
serum
would
expect
provid
direct
protect
strictli
enter
infect
pedv
data
suggest
correl
detect
neutral
antibodi
level
serum
present
milk
colostrum
previous
expos
vaccin
sow
correl
pedv
neutral
result
elisa
result
exist
describ
literatur
one
studi
perform
compar
analysi
wholeviru
antigen
elisa
serum
neutral
test
serodiagnosi
pedv
presenc
antibodi
confirm
test
overal
test
agreement
demonstr
use
field
serum
sampl
furthermor
pairwis
correl
perform
show
correct
cutoff
valu
elisa
od
sn
titer
r
valu
indic
cpebas
neutral
test
roughli
reliabl
elisa
test
newer
technolog
fmia
use
detect
antibodi
multipl
antigen
simultan
surveil
purpos
fmia
bead
base
assay
simultan
high
throughput
detect
antibodi
multipl
antigen
fmia
differ
elisa
sinc
involv
fluid
incub
step
bead
suspend
solut
allow
higher
surfac
area
exposur
dimens
therefor
shorter
diffus
path
antibodi
bind
site
antigen
coat
bead
result
rapid
reaction
time
instead
method
use
enzymat
reaction
elisa
fmia
detect
laser
technolog
result
shorter
detect
time
pedv
antigen
specif
bead
set
mix
addit
coat
bead
antigen
siv
prrsv
pathogen
simultan
detect
antibodi
antigen
addit
fmia
could
develop
differenti
wildtyp
infect
vs
vaccin
anim
diva
protein
use
vaccin
differ
produc
wildtyp
infect
individu
kinet
serum
igg
igm
level
measur
fmia
experiment
infect
anim
time
appear
igm
subclass
consid
immunolog
paramet
earli
infect
gener
appear
prior
appear
igg
confirm
studi
contrast
data
woo
et
al
unabl
detect
igm
antibodi
use
npbase
indirect
elisa
igg
antibodi
may
easili
detect
character
higher
antigen
affin
lower
avid
igm
understand
variou
antibodi
profil
provid
import
inform
abil
vaccin
stimul
protect
immun
respons
wellvalid
na
pedv
ielisa
belisa
fmia
ffn
assay
use
rang
serolog
investig
serv
complement
nucleic
acid
detect
determin
pedv
statu
asymptomat
individu
costeffect
tool
manag
strategi
monitor
viru
exposur
within
herd
fmia
use
isotyp
antibodi
respons
multiplex
determin
exposur
multipl
pathogen
simultan
addit
ffn
use
determin
whether
antibodi
measur
provid
biolog
function
block
viru
infect
work
ongo
valid
assay
sampl
matric
milk
colostrum
measur
passiv
transfer
antibodi
oral
fluid
penbas
surveil
